CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 136 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $98,000 | -46.7% | 66,400 | -29.2% | 0.01% | 0.0% |
| Q4 2019 | $184,000 | -61.2% | 93,829 | 0.0% | 0.01% | -72.2% |
| Q3 2019 | $474,000 | -28.5% | 93,829 | +1.3% | 0.02% | -35.7% |
| Q2 2019 | $663,000 | -43.0% | 92,638 | +5.8% | 0.03% | -47.2% |
| Q1 2019 | $1,163,000 | +68.8% | 87,575 | 0.0% | 0.05% | +76.7% |
| Q4 2018 | $689,000 | -29.3% | 87,575 | -0.5% | 0.03% | -41.2% |
| Q3 2018 | $975,000 | -17.4% | 88,007 | 0.0% | 0.05% | -48.0% |
| Q2 2018 | $1,181,000 | +50.4% | 88,007 | +45.7% | 0.10% | -5.8% |
| Q1 2018 | $785,000 | +31.7% | 60,407 | -6.8% | 0.10% | +22.4% |
| Q4 2017 | $596,000 | – | 64,800 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |